45.78M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It also develops Remetinostat for treating MF cutaneous T-cell lymphoma, as well as basal cell carcinoma.

Similar securities

Based on sector and market capitalization

Report issue